ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

HEPA Hepion Pharmaceuticals Inc

1.37
0.08 (6.20%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Hepion Pharmaceuticals Inc HEPA NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.08 6.20% 1.37 15:30:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.29 1.27 1.44 1.37 1.29
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
19/4/202415:30GLOBEHepion Pharmaceuticals Initiates Wind-Down Activities in..
16/2/202408:02EDGAR2Form 8-K - Current report
16/2/202407:00GLOBEHepion Pharmaceuticals Announces Exercise of Warrants for..
14/2/202414:38EDGAR2Form SC 13G - Statement of acquisition of beneficial..
03/1/202416:15GLOBEHepion Pharmaceuticals to Present at NASH-TAG 2024
03/1/202415:30EDGAR2Form 8-K - Current report
07/12/202307:00GLOBEHepion Pharmaceuticals Announces Restructuring Plan to..
28/11/202315:15GLOBEHepion Pharmaceuticals to Present at the 7th Obesity & NASH..
13/11/202315:05GLOBEHepion Pharmaceuticals Announces Major Reductions in Liver..
10/11/202307:50GLOBEHepion Pharmaceuticals Schedules Conference Call to Review..
08/11/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
25/10/202307:30GLOBEHepion Pharmaceuticals’ Rencofilstat Demonstrates..
29/9/202307:00GLOBEHepion Pharmaceuticals Announces $5.0 Million Registered..
21/9/202315:05GLOBEHepion Pharmaceuticals to Participate in 2023 Cantor Global..
21/9/202307:00GLOBENew Anti-Cancer Opportunities Revealed for Hepion..
19/9/202308:00GLOBEHepion Pharmaceuticals Discovers Novel Rencofilstat Action..
18/9/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202307:45GLOBERencofilstat Produces Positive Outcomes in Translational..
06/9/202315:40EDGAR2Form 8-K - Current report
06/9/202315:30GLOBEHepion Pharmaceuticals Announces Management Changes
24/7/202315:04EDGAR2Form 8-K - Current report
21/7/202315:41EDGAR2Form 8-K - Current report
21/7/202315:39EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/6/202315:45GLOBEHepion Pharmaceuticals to Present Two Posters at EASL..
15/6/202307:22GLOBEHepion Pharmaceuticals Announces Passing of Key Safety..
24/5/202315:45GLOBEHepion Pharmaceuticals to Highlight AI-POWR™ at the 2023..
22/5/202306:00GLOBEHepion Pharmaceuticals’ Phase 2 ‘ALTITUDE-NASH’ Trial..
19/5/202315:05GLOBEHepion Pharmaceuticals Schedules Conference Call to Review..
10/5/202310:15GLOBEHepion Pharmaceuticals, Inc. Announces Reverse Stock Split

Su Consulta Reciente

Delayed Upgrade Clock